•
States Sue 23andMe to Protect Genetic Data Privacy Amid Bankruptcy Sale
Twenty-seven states and D.C. are suing 23andMe to block the sale of personal genetic data without customer consent during its bankruptcy proceedings.
Overview
A summary of the key points of this story verified across multiple sources.
1.
Twenty-seven states and the District of Columbia are suing 23andMe over the unauthorized sale of genetic data.
2.
The lawsuit emphasizes the need for customer consent regarding sensitive personal information.
3.
23andMe filed for Chapter 11 bankruptcy in March 2023, laying off 40% of its staff.
4.
Regeneron Pharmaceuticals plans to acquire 23andMe for $256 million, facing legal challenges from multiple states.
5.
An independent consumer privacy ombudsman has been appointed to evaluate the impact on consumer privacy amidst the legal actions.
Written using shared reports from .
3 sources
Report issue
Analysis
Compare how each side frames the story — including which facts they emphasize or leave out.